|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.930 USD | +1.05% |
|
+12.21% | -17.87% |
| 04-07 | Clover Health Investments Corp and Healthex Enter Strategic Alliance | CI |
| 04-01 | Clover Health Investments, Corp. Announces Chief Financial Officer Changes | CI |
| Capitalization | 1.01B 864M 798M 752M 1.4B 94.22B 1.43B 9.39B 3.66B 45.22B 3.8B 3.72B 161B | P/E ratio 2026 * |
-270x | P/E ratio 2027 * | 193x |
|---|---|---|---|---|---|
| Enterprise value | 863M 736M 680M 641M 1.19B 80.31B 1.22B 8.01B 3.12B 38.54B 3.24B 3.17B 137B | EV / Sales 2026 * |
0.3x | EV / Sales 2027 * | 0.23x |
| Free-Float |
75.33% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Clover Health Investments, Corp.
| 1 day | +1.05% | ||
| 1 week | +12.21% | ||
| Current month | +9.66% | ||
| 1 month | -4.46% | ||
| 3 months | -25.77% | ||
| 6 months | -24.61% | ||
| Current year | -17.87% |
| 1 week | 1.73 |  | 2.01 |
| 1 month | 1.58 | | 2.03 |
| Current year | 1.58 | | 2.88 |
| 1 year | 1.58 | | 3.92 |
| 3 years | 0.61 | | 4.87 |
| 5 years | 0.61 | | 28.85 |
| 10 years | 0.61 | | 28.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Toy
CEO | Chief Executive Officer | 47 | 31/12/2022 |
Conrad Wai
CTO | Chief Tech/Sci/R&D Officer | 45 | 27/02/2022 |
Wendy Richey
CMP | Compliance Officer | - | 29/02/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Vivek Garipalli
CHM | Chairman | 47 | 31/12/2022 |
Andrew Toy
BRD | Director/Board Member | 47 | 31/10/2018 |
William Robinson
BRD | Director/Board Member | 61 | 24/03/2021 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -1.09% | 0.02% | 300 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.05% | +12.21% | -47.55% | +128.56% | 1.01B | |
| -0.84% | +9.76% | -49.23% | -41.58% | 276B | |
| -2.59% | +0.46% | -17.85% | +1.79% | 71.52B | |
| -1.69% | +3.59% | -29.17% | -36.38% | 68.43B | |
| -2.62% | +8.05% | -34.87% | -64.00% | 23.07B | |
| -0.67% | +6.24% | -41.59% | -44.63% | 18.34B | |
| +0.57% | +4.66% | -57.72% | -50.42% | 7.6B | |
| -4.12% | +9.28% | +3.85% | +168.32% | 4.19B | |
| -1.39% | -1.81% | -27.04% | -50.08% | 1.28B | |
| +0.81% | +10.87% | -20.87% | - | 286M | |
| Average | -1.15% | +6.04% | -32.20% | +1.29% | 47.2B | |
| Weighted average by Cap. | -1.31% | +7.11% | -40.15% | -33.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.88B 2.46B 2.27B 2.14B 3.98B 268B 4.08B 26.69B 10.41B 129B 10.8B 10.57B 458B | 3.32B 2.83B 2.62B 2.47B 4.59B 309B 4.7B 30.79B 12.01B 148B 12.46B 12.19B 529B |
| Net income | -4.48M -3.83M -3.54M -3.33M -6.21M -417M -6.35M -41.59M -16.23M -200M -16.83M -16.47M -714M | 4.87M 4.15M 3.84M 3.62M 6.74M 453M 6.89M 45.14M 17.61M 217M 18.26M 17.88M 775M |
| Net Debt | -150M -128M -118M -111M -207M -13.91B -212M -1.39B -541M -6.68B -561M -549M -23.81B | -240M -205M -190M -179M -333M -22.37B -340M -2.23B -870M -10.74B -902M -883M -38.28B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/04/26 | 1.930 $ | +1.05% | 4,795,748 |
| 09/04/26 | 1.910 $ | -0.52% | 2,249,147 |
| 08/04/26 | 1.920 $ | +1.05% | 5,961,788 |
| 07/04/26 | 1.900 $ | +1.60% | 7,510,073 |
| 06/04/26 | 1.870 $ | +8.72% | 7,806,329 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CLOV Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition